Newsfeeds - Spark Newswire

1 minute read

Nervous System Firm Eliem Therapeutics Files For $80M IPO

Today, 7:47 AM

Eliem Therapeutics (NASDAQ: ELYM), a Phase 2a biotech developing therapies for neuronal excitability disorders, filed an IPO prospectus with the SEC to raise up to $80 million. Its two lead candidates are ETX-810 and ETX-155.

ELYM

1 minute read

Skin-Disease Focused Biotech Castle Creek Files $100M IPO

By Vandana Singh

Today, 7:47 AM

Ahead of Phase 3 data readout in the second half of next year, Castle Creek Biosciences Inc (NASDAQ: CCBS) seeks to make NASDAQ debut under the symbol CCBS.

CCBS

1 minute read

Adagio Files $100M IPO To Take Its COVID-19 Antibody Through Commercialization In 2022

By Vandana Singh

Today, 7:47 AM

Adagio Therapeutics has filed an initial public offering to raise money to bring its COVID-19 antibody to market. The $100 million IPO will support Phase 2/3 trials that CEO Tillman Gerngross’ Adagio is running to position ADG20 to treat and prevent COVID-19.

FPX

1 minute read

Celularity Closes SPAC Merger With GX Acquisition, Trading Starts Monday

By Vandana Singh

Today, 7:47 AM

Celularity Inc has closed the merger with GX Acquisition Corp (NASDAQ:GXGX), giving Celularity $138 million to push the NK cell and…

CELU

1 minute read

Alibaba, SoftBank Backed Indian Online Payment Startup Paytm Eyes $2.2B IPO: TechCrunch

By Anusuya Lahiri

Today, 7:47 AM

Indian digital payments startup, Paytm, plans to raise $2.2 billion in an initial public offering, TechCrunch reports.

BABA

1 minute read

Ocular Medical Device Firm Sight Sciences Sets Terms For $150M IPO

By Vandana Singh

Today, 7:47 AM

Ophthalmic device developer Sight Sciences (NASDAQ: SGHT) hopes to see its way to nearly a $1 billion valuation through a $150 million Nasdaq debut.

FPX

1 minute read

Precision Oncology-Focused Biotech Nuvalent Files For $100M IPO

By Vandana Singh

Today, 7:47 AM

Less than six months after emerging from stealth, the Deerfield-backed biotech Nuvalent (NASDAQ: NUVL) is already prepping a Nasdaq debut.

FPX

1 minute read

Rare Disease Biotech Rallybio Targets $100M IPO

By Vandana Singh

Today, 7:47 AM

Rallybio Corporation (NASDAQ:RLYB) ended the first quarter with nearly $128 million in the bank, and now it has filed to…

FPX

1 minute read

GIC-Backed WCG Clinical Plans $100M NASDAQ Debut

By Vandana Singh

Today, 7:47 AM

WCG Clinical Inc (NASDAQ: WCGC), a clinical trial solutions company backed by Singapore's sovereign wealth fund GIC, filed for an initial public offering in the U.S. on Thursday to trade on NASDAQ under the "WCGC" symbol.

FPX